Clinical Experience With Daptomycin in Patients With Orthopedic-Related Infections
- 1 May 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 14 (3) , 144-149
Abstract
A retrospective chart review was performed for all patients (N = 31) treated by the authors with daptomycin over a 12-month period for infections of bone and joints, spine, and prostheses. Data were collected for demographic patient information, therapy duration, surgical procedures, culture site and results, side effects, and clinical outcomes. Infection types included osteomyelitis (n = 16), prosthetic joints (n = 8), laminectomy wounds without osteomyelitis (n = 6), and diskitis with bacteremia (n = 1). Twenty-four patients' infections involved methicillin-resistant Staphylococcus aureus isolates (MRSA); 5 had methicillin-sensitive S. aureus (MSSA); and 4 had methicillin-resistant Staphylococcus epidermidis (MRSE). Most received daptomycin as salvage therapy at dosages of 6 mg/kg/d; mean therapy duration was 38 days (range 14-56). Daptomycin therapy was successful in 87% (27/31) of patients, determined by culture results, and magnetic resonance imaging (MRI) and computed tomography (CT) scans. In most cases, daptomycin was effective for treatment of difficult bone and joint infections caused by MRSA in this patient population.Keywords
This publication has 27 references indexed in Scilit:
- Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?International Journal of Infectious Diseases, 2005
- Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin TherapyAntimicrobial Agents and Chemotherapy, 2005
- Daptomycin‐Resistant, Methicillin‐ResistantStaphylococcus aureusBacteremiaClinical Infectious Diseases, 2005
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004
- In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance DeterminantsAntimicrobial Agents and Chemotherapy, 2004
- Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Infected Pressure Ulcers in Elderly IndividualsClinical Infectious Diseases, 2002
- Resistance Studies with DaptomycinAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Daptomycin against 2,789 Clinical Isolates from 11 North American Medical CentersAntimicrobial Agents and Chemotherapy, 2001
- Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive PathogensAntimicrobial Agents and Chemotherapy, 2000